Neoadjuvant chemotherapy in inoperable, locally advanced, and inflammatory breast carcinoma: A pilot study of MTT assay in vitro and outcome analysis of 10 patients

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 3, 2001, Pages 259-263

  Xu, Jian Ming ^a,b   Song, San Tai ^a   Tang, Zhong Ming ^a   Jiang, Ze Fei ^a   Liu, Xiao Qing ^a   Zhang, Jing ^a   Liu, Xiu Wen ^a   Paradiso, Angelo ^a,b  

^a Beijing 307 Hospital   (China)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Chemosensitivity in vitro; Locally advanced breast carcinoma; MTT assay; Neoadjuvant chemotherapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; VINDESINE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CHEMOSENSITIVITY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY DISEASE; INOPERABLE CANCER; LYMPH NODE METASTASIS; MASTECTOMY; MEDICAL INFORMATION; MULTIMODALITY CANCER THERAPY; PILOT STUDY; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE TREATMENT; PROGNOSIS;

ADENOCARCINOMA; ADULT; BREAST NEOPLASMS; COLORING AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0034989459     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200106000-00010     Document Type: Article

References (22)

1. Inflammatory carcinoma of the breast
2. Inflammatory breast cancer: A review
3. Locally advanced breast cancer: Early results of a randomised trial of multimodal therapy versus initial hormone therapy
4. Evolving concepts in the systemic drug therapy of breast cancer
5. Management of metastatic breast cancer
6. Systemic treatment for locally advanced breast cancer: What we still need to learn after a decade of multimodality clinical-trial
7. Treatment of locally advanced and inflammatory breast
8. Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapy: An EORTC breast cancer cooperative group trial (10792)
9. Evaluation of in vitro chemosensitivity to antitumor drugs using the chemosensitivity testing in fresh breast cancer
10. Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro
11. Reporting result of cancer treatment
12. Pathological assessment of response to induction chemotherapy in breast cancer
13. The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid binding assay
14. Breast cancer: Relation between the size of the primary tumor and the probability of metastatic dissemination
15. Breast tumor response to primary chemotherapy predicts local and distant control as well as survival
16. Primary chemotherapy in breast cancer: Correlation between tumor response and patient outcome
17. Primary chemotherapy in surgically resectable breast cancer
18. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more
19. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma
20. Inflammatory breast cancer: Integration of irradiation, surgery, and chemotherapy
21. Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer
22. Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy